ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,22
-1,51%
Dow Jones
42 732,13
0,80%
DAX
19 906,08
-0,49%
Brent Oil
76,495
0,00%
Bitcoin
98 166,82
-0,04%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSXV

  6. Kane Biotech Inc (KNE) Cours

Kane Biotech Inc

Kane Biotech Inc (KNE)

TSXV
0,11
0,00
(0,00%)
Fermé 05 Janvier 10:00PM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
0,11
Prix Achat
0,105
Prix Vente
0,11
Volume échangé
30 500
0,11 Fourchette du Jour 0,11
0,00 Plage de 52 semaines 0,00
Cap du marché
14,503M
Clôture Veille
0,11
Ouverture
0,11
Dernière Transaction
5000
@
0.11
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
131 844 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-2,75
Bénéfice par action (BPA)
-0,04
Chiffre d'affairess
2,82M
Bénéfice net
-5,27M

À propos de Kane Biotech Inc

Secteur
Coml Physical, Biologcl Resh
Industrie
Coml Physical, Biologcl Resh
Site Web
www.kanebiotech.com
Siège social
Winnipeg, Manitoba, Can
Fondé
-
Kane Biotech Inc est coté dans le secteur Coml Physical, Biologcl Resh de la TSX Venture Exchange avec le ticker KNE. Le dernier cours de clôture d'Kane Biotech était de $0,11. Au cours de la dernière année, les actions de Kane Biotech ont été négociées dans une fourchette de prix de $ 0,00 à $ 0,00.

Kane Biotech compte actuellement 131 844 000 actions en circulation. La capitalisation boursière d'Kane Biotech est de $14,50 million. Kane Biotech a un ratio cours/bénéfice (ratio PE) de -2.75.

KNE Dernières nouvelles

Plus de nouvelles

Kane Biotech Announces $3,000,000 Private Placement Offering

WINNIPEG, Manitoba, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that it intends to undertake a non-brokered...

03 Décembre 2024
GlobeNewswire Inc.

Kane Biotech Announces Third Quarter 2024 Financial Results

WINNIPEG, Manitoba, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) today announces its third quarter 2024 financial...

28 Novembre 2024
GlobeNewswire Inc.

Kane Biotech Announces Change in US Distribution Partner for revyve™ Antimicrobial Wound Gel

WINNIPEG, Manitoba, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane Biotech” or “Kane”) announces today that BioStem Technologies Inc...

27 Novembre 2024
GlobeNewswire Inc.

Kane Biotech to Release Third Quarter 2024 Financial Results on November 28, 2024

WINNIPEG, Manitoba, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”) will release its third quarter 2024 financial results after market close on...

21 Novembre 2024
GlobeNewswire Inc.

Kane Biotech Announces Health Canada Approval of revyve™ Antimicrobial Wound Gel

WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that it has received Health Canada approval of...

14 Novembre 2024
GlobeNewswire Inc.

Kane Biotech Provides Investor Update Following FB Dermatology Acquisition Announcement

WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane Biotech”) announces today that President & CEO, Marc Edwards and Dr...

14 Novembre 2024
GlobeNewswire Inc.

Kane Biotech Announces Agreement to Acquire FB Dermatology

WINNIPEG, Manitoba, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane Biotech”) announces today that it has entered into a binding term sheet...

12 Novembre 2024
GlobeNewswire Inc.

Kane Biotech Announces Donation of revyve™ Antimicrobial Wound Gel to Ukraine

WINNIPEG, Manitoba, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it is donating 2,000 ounces of revyve™ Antimicrobial...

23 Octobre 2024
GlobeNewswire Inc.

Kane Biotech Announces Exclusive Distribution Agreement With XSONX

WINNIPEG, Manitoba, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has signed an exclusive five year distribution...

17 Octobre 2024
GlobeNewswire Inc.

Kane Biotech to Participate in a Multinational Corporate Collaboration Project

WINNIPEG, Manitoba, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that it is receiving advisory services and...

03 Octobre 2024
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

KNE - Frequently Asked Questions (FAQ)

What is the current Kane Biotech share price?
The current share price of Kane Biotech is $ 0,11
How many Kane Biotech shares are in issue?
Kane Biotech has 131 844 000 shares in issue
What is the market cap of Kane Biotech?
The market capitalisation of Kane Biotech is CAD 14,5M
What is the 1 year trading range for Kane Biotech share price?
Kane Biotech has traded in the range of $ 0,00 to $ 0,00 during the past year
What is the PE ratio of Kane Biotech?
The price to earnings ratio of Kane Biotech is -2,75
What is the cash to sales ratio of Kane Biotech?
The cash to sales ratio of Kane Biotech is 5,14
What is the reporting currency for Kane Biotech?
Kane Biotech reports financial results in CAD
What is the latest annual turnover for Kane Biotech?
The latest annual turnover of Kane Biotech is CAD 2,82M
What is the latest annual profit for Kane Biotech?
The latest annual profit of Kane Biotech is CAD -5,27M
What is the registered address of Kane Biotech?
The registered address for Kane Biotech is 290-100 INNOVATION DRIVE, WINNIPEG, MANITOBA, R3T 6G2
What is the Kane Biotech website address?
The website address for Kane Biotech is www.kanebiotech.com
Which industry sector does Kane Biotech operate in?
Kane Biotech operates in the COML PHYSICAL, BIOLOGCL RESH sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MUST.HMust Capital Inc
$ 0,06
(200,00%)
165k
KUAI.PKua Investments Inc
$ 0,045
(125,00%)
14k
CRBKCarebook Technologies Inc
$ 0,095
(111,11%)
420,1k
CPLCopper Lake Resources Ltd
$ 0,01
(100,00%)
9k
VKG.HNorse Gold Corp
$ 0,02
(100,00%)
2,16k
TVITVI Pacific Inc
$ 0,005
(-50,00%)
11k
ETUE2gold Inc
$ 0,005
(-50,00%)
10k
MTBMTB Metals Corp
$ 0,01
(-50,00%)
116,4k
KOVOKovo+ Holdings Inc
$ 0,035
(-41,67%)
15k
PORPortofino Resources Inc
$ 0,01
(-33,33%)
349k
MATEBlockmate Ventures Inc
$ 0,41
(38,98%)
9,03M
DMDataMetrex AI Limited
$ 0,005
(0,00%)
4,48M
THRMTherma Bright Inc
$ 0,04
(14,29%)
3,45M
GPUSAlset AI Ventures Inc
$ 0,16
(-3,03%)
2,41M
SSESilver Spruce Resources Inc
$ 0,005
(0,00%)
2,14M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

TSXV
KNE
Kane Biotech
BIT
P13IH4
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés